Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): A multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO)

Lung Cancer

Volumn 48, Issue 1, 2005, Pages 121-127

  Tibaldi, C ^a   Ricci, S ^b   Russo, F ^a   Bernardini, I ^a   Galli, L ^b   Chioni, A ^b   Orlandini, C ^b   Grosso, A M ^b   Lopes Pegna, A ^c   Fabbri, A ^d   Innocenti, F ^d   Ferrari, K ^c   Tognarini, L ^e   Conte, P F ^b   Falcone, A ^a,f  

^a Division of Medical Oncology   (Italy)

^b Division of Medical Oncology   (Italy)

^c 1st Division of Pneumology   (Italy)

^d Division of Pneumology   (Italy)

^e Division of Medical Oncology   (Italy)

^f UNIVERSITY OF PISA   (Italy)

Author keywords

Dose intensity; Elderly; Gemcitabine; NSCLC

Indexed keywords

GEMCITABINE;

ADVANCED CANCER; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG INFUSION; DRUG TOLERABILITY; ELDERLY CARE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOCYTOPENIA; TOXICITY; TREATMENT OUTCOME; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 20144366834     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.10.008     Document Type: Article

References (27)

1. T.L. Lee-Chiong Jr., and R.A. Matthay Lung cancer in the elderly patient Clin Chest Med 14 1993 453 478
2. P.J. Souquet, F. Chauvin, J.P. Boissel, R. Cellerino, Y. Cormier, and P.A. Ganz Polychemotherapy in advanced non small cell lung cancer: a meta-analysis Lancet 342 1993 19 21
3. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using up-dated data on individual patients from 52 randomised clinical trials Br Med J 311 1995 899 909
4. F. Oshita, T. Kurata, T. Kasai, M. Fakuda, N. Yamamoto, and Y. Ohe Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ function Jpn J Cancer Res 86 1995 1198
5. P.J. Soquet, P. Bombaron, and J. Brunel-Crova Treatment of advanced and disseminated non small cell lung cancer (NSCLC) in elderly patients: results of MIC regimen Lung Cancer 18 Suppl. 1 1997 24
6. L. Balducci Geriatric oncology: challenge for new century Eur J Cancer 36 2000 1741 1754
7. C. Gridelli, F. Perrone, C. Gallo, F. De marinis, G.P. Ianniello, and S. Cigolari Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non small cell lung cancer A two stage phase II study Eur J Cancer 33 1997 392 397
8. F.A. Shepherd, R.P. Abratt, H. Anderson, U. Gatzemeier, G. Angling, and J. Iglesias Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer Semin Oncol 24 2 Suppl 7 1997 S7-50 S7-55
9. S. Ricci, A. Antonuzzo, L. Galli, C. Tibaldi, M. Bertuccelli, and A. Lopes-Pegna Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study Lung Cancer 27 2000 75 80
10. J. Wilson, R.L. Bunkes, F.A. Shepherd, S. Spadafora, and J. Iglesias Single agent gemcitabine for elderly patients with non small cell lung cancer Proc Am Soc Clin Oncol 19 2000 547a
11. A.J. Wozniak Single-agent vinorelbine in the treatment of non-small cell lung cancer Semin Oncol 26 1999 62 66
12. The Elderly Lung Cancer Vinorelbine Italian Study Group Effects of Vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell-lung cancer J Natl Cancer Inst 91 1999 66 72
13. H. Anderson, B. Lund, F. Bach, N. Thatcher, J. Walling, and H.H. Hansen Single-agent activity of weekly gemcitabine in advanced non-small cell lung cancer. A phase II study J Clin Oncol 12 1994 1821 1826
14. U. Gatzmeier, F.A. Shepherd, and T. Le Chevalier Activity of gemcitabine in patients with non-small cell lung cancer A multicentre extended phase II study Eur J Cancer 32A 1996 243 248
15. H. Anderson, P. Hopwood, R.J. Stephens, N. Thatcher, B. Cottier, and M. Nicholson Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome Br J Cancer 83 2000 447 453
16. D.D. Von Hoff Activity of gemcitabine in human tumor cloning assay as a basis for clinical trials with gemcitabine: San Antonio Drug Development Team Invest New Drugs 14 1996 265 270
17. K. Csoka, J. Liliemark, and R. Larsson Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors Semin Oncol 22 4 Suppl. 11 1995 47 53
18. M.M. Oken, R.H. Greech, D.C. Tormey, J. Horton, T.E. Davis, and E.T. Mc Fadden Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
19. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 47 1981 207 214
20. E. Kaplan, and P. Meier Non-parametric estimation from incomplete observations J Am Stat Assoc 53 1993 1245 1252
21. C. Gridelli, F. Perrone, C. Gallo, S. Cigolari, A. Rossi, and F. Piantedosi Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial JNCI 95 2003 362 372
22. J. Feliu, L.L. Gomez, C. Madronal, E. Espinosa, J. Espinosa, and C.G. Giron Gemcitabine plus vinorelbine in non small cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin Cancer 86 1999 1463
23. G.D. Beretta, G. Michetti, M.O. Belometti, G. Critti, A. Quadri, and P. Poletti Gemcitabine plus vinorelbine in elderly or unfit patients with non small cell lung cancer Br J Cancer 83 2000 573
24. C.J. Langer, J. Manola, P. Bernardo, J.W. Kugler, P. Bonomi, and D. Cella Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial JNCI 94 3 2002 173 181
25. F. Perrone, C. Gallo, and C. Gridelli Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial JNCI 94 13 2002 1029
26. R.C. Lilienbaum, J. Herndon, M. List, C. Desch, D. Watson, and J. Holland Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a CALGB randomized trial of efficacy, quality of life and cost effectiveness Proc ASCO 21a 2002 1a (Abstract 2)
27. Sederholm C. Gemcitabine (G) compared with gemcitabine plus carboplatin (GC) in advanced non-small cell lung cancer (NSCLC): a phase III study by the Swedish Lung Cancer Study Group (SLUSG). Proc ASCO 2002;21:291a (Abstract 162).